There is a need for biomarkers to detect early joint inlammation and destruction of cartilage in diferent types of arthritis. YKL-40, a 39 kDa heparin-and chitin-binding secreted glycoprotein (also known as human cartilage gp39), has been recently discovered. Its exact biological function is still unclear. Speciic receptors for YKL-40 have not been identiied yet. The clinical signiicance of YKL-40 as a biomarker is discussed in diferent aspects. High level of YKL-40 is found in various human i`nlammatory and neoplastic diseases. We present a review highlighting the information available on YKL-40 and its signiicance in inlammatory joint diseases, like rheumatoid arthritis (RA). We also report original personal data on the topic concerning YKL-40 levels in serum and synovial luid of patients with RA in comparison with ultrasonographic parameters and cytokine levels. The indings suggest that YKL-40 might be implicated in the pathogenesis of the disease and could indicate the level of joint inlammation.